New India Biopharma Profile
Key Indicators
- Authorised Capital ₹ 2.00 Cr
as on 14-12-2024
- Paid Up Capital ₹ 1.71 Cr
as on 14-12-2024
- Company Age 13 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Revenue 211.61%
(FY 2017)
- Profit 75.97%
(FY 2017)
- Ebitda 87.39%
(FY 2017)
- Net Worth -33.77%
(FY 2017)
- Total Assets 6.02%
(FY 2017)
About New India Biopharma
The Company is engaged in the Financial Services Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.00 Cr and a paid-up capital of Rs 1.71 Cr, as per Ministry of Corporate Affairs (MCA) records.
Randeep Singh and Rakesh Ahuja serve as directors at the Company.
- CIN/LLPIN
U51397DL2011PTC215424
- Company No.
215424
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
08 Mar 2011
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at New India Biopharma?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Randeep Singh  | Director | 14-Dec-2018 | Current |
| Rakesh Ahuja | Director | 13-Apr-2021 | Current |
Financial Performance of New India Biopharma.
New India Biopharma Private Limited, for the financial year ended 2017, experienced significant growth in revenue, with a 211.61% increase. The company also saw a substantial improvement in profitability, with a 75.97% increase in profit. The company's net worth observed a substantial decline by a decrease of 33.77%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of New India Biopharma?
In 2017, New India Biopharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at New India Biopharma?
Unlock and access historical data on people associated with New India Biopharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of New India Biopharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped New India Biopharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
